Accustem Sciences Inc ACUT
Trading Information
- Previous Close Price
- $0.15
- Day Range
- $0.15–0.16
- 52-Week Range
- $0.12–1.67
- Bid/Ask
- $0.14 / $0.16
- Shares Outstanding
- 16.07M
- Market Cap
- $2.37M
- Volume/Avg
- 12,846 / 9,608
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Accustem Sciences Inc is a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the millions of people who are diagnosed with cancer each year. The company's product, StemPrintER, is a genomic platform for predicting distant recurrence risk in luminal, ER+/HER2-negative breast cancer patients. Additionally, It offers ancillary commodity testing to provide further insights. Validated in various retrospective cohorts, StemPrintER shows promise for oncology clinics. Revenue is generated through product commercialization and testing services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.accustem.com
Valuation
|
Metric
|
ACUT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACUT
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.02 |
Interest Coverage | — |
Quick Ratio
ACUT
Profitability
|
Metric
|
ACUT
|
|---|---|
Return on Assets (Normalized) | −100.29% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ACUT
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|TvdM%W | LOCK|%<#@ | $128B | |||
| Moderna Inc
MRNA
| LOCK|JM$!p< | LOCK|v@ | $79B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#!$@JC< | LOCK|hpb? | $76B | |||
| argenx SE ADR
ARGX
| LOCK|zfN!YYg | LOCK|#>? | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>$$b&# | LOCK|<QZ | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|!rMc&>> | LOCK|w<&V | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|$M^!%VRG | LOCK|<?ZN | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|>h><d$Z | LOCK|Hx | $23B | |||
| Incyte Corp
INCY
| LOCK|Z<b^VP | LOCK|X% | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|!gvzzvW | LOCK|zS$ | $14B |
United States